Overview
- 9 FDA inspections are on record.
- 6 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-08-28.
At a glance
Inspections
9
Form 483s
6
EIRs
0
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 26 Aug 2025 – 28 Aug 2025 | Biologics | Clean | |
| 13 Sep 2023 – 20 Sep 2023 | Biologics | 483 | View 483 → |
| 27 Sep 2021 – 29 Oct 2021 | Biologics | 483 | View 483 → |
| 13 Feb 2019 – 25 Feb 2019 | Biologics | WL | View 483 → |
| 8 Dec 2016 – 9 Dec 2016 | Biologics | WL | |
| 20 May 2014 – 4 Jun 2014 | Biologics | 483 | On file |
| 30 Apr 2013 – 12 Jun 2013 | Biologics | 483 | View 483 → |
| 11 Jan 2011 | Not recorded | Clean | |
| 29 Jul 2009 | Not recorded | 483 | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
20 Sep 2023
21 CFR 1271.47(a)
Testing, screening, donor eligibility procedures
Cited by La-Tasha M Gunter
29 Oct 2021
21 CFR 1271.75(a)(1)
Risk factors, clinical evidence
Cited by Richard J Bashay, Kenneth L Smalls
29 Oct 2021
21 CFR 1271.75(a)(1)
Risk factors, clinical evidence
Cited by Richard J Bashay, Kenneth L Smalls
Investigators
FDA investigators tied to this site in the record.
Courtney N Long3 insp.
Randy L Clarida1 insp.
La-Tasha M Gunter1 insp.
Richard J Bashay1 insp.
Kenneth L Smalls1 insp.
Shavon L Square1 insp.
Brian M Palermo1 insp.
Margaret Torres-Vazquez1 insp.
Susan J Essenmacher1 insp.
Tamika E Allen1 insp.
Sarah M Forney1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 1271.47(a) | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 1271.75(a)(1) | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 1271.65(b)(2) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 1271.90(c) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 1271.50(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 1271.50(b)(1) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 1271.55(b)(2) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 1271.75(d) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 1271.80(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 1271.55(d)(1)(iii) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 1271.55(a)(3) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.55(d)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.60(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.80(d)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.85(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Virginia Center for Reproductive Medicine's 6 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat